missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ ENY2 Polyclonal Antibody
Description
Recommended positive controls: NT2D1, PC-3, U87-MG, SK-N-SH. Predicted reactivity: Mouse (100%), Rat (100%), Zebrafish (86%), Xenopus laevis (93%), Pig (100%), Chicken (96%), Rhesus Monkey (100%), Bovine (100%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
ENY2 is a component of the transcription regulatory histone acetylation (HAT) complex SAGA, a multiprotein complex that activates transcription by remodeling chromatin and mediating histone acetylation and deubiquitination. Within the SAGA complex, participates in a subcomplex that specifically deubiquitinates both histones H2A and H2B. The SAGA complex is recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Required for nuclear receptor-mediated transactivation. May also participate in mRNA export and accurate chromatin positioning in the nucleus by tethering genes to the nuclear periphery.
Specifications
Specifications
| Antigen | ENY2 |
| Applications | Immunoprecipitation, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.62 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 20% glycerol and 0.025% ProClin 300; pH 7 |
| Gene | ENY2 |
| Gene Accession No. | Q9NPA8 |
| Gene Alias | 1810057B09Rik; 6720481I12; DC6; e(y)2; e(y)2 homolog; e(y)2 protein; enhancer of yellow 2 homolog; enhancer of yellow 2 homolog (Drosophila); enhancer of yellow 2 transcription factor homolog; enhancer of yellow eye homolog; ENY 2; ENY2; ENY-2; ENY2, transcription and export complex 2 subunit; Ey2; Sus1; transcription and mRNA export factor ENY2 |
| Gene Symbols | ENY2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?